Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
23 results
D2.138 - Type 3 cytokine - dependent E3 epithelial programming is driven by a novel transcriptional regulator that impacts airway barrier integrity in asthma
D2.142 - Longitudinal Airway Immune Responses to Respiratory Viruses in Asthmatic and Atopic Children
D2.146 - Neuropsychiatric events associated with montelukast in children: a systematic review
D2.135 - Preventive counseling regarding the risk factors for individuals with asthma or chronic obstructive pulmonary disease
D2.139 - Atypical Presentation of House Dust Mite–Induced Atopic Asthma in an Adolescent Girl: A Case Report from a Remote Region of Kyrgyzstan
D2.141 - Predictors of inpatient admission amongst children presenting with acute asthma exacerbation: influence of the patient’s prior clinical profile
D2.143 - Cypress pollen as a major aeroallergen in paediatric respiratory allergy: experience in Gaziantep, south-eastern Türkiye
D2.144 - Bronchial Inflammation and Lung Function in Children with Asthma and Allergic Rhinitis: The Contribution of FeNO and Spirometry
D2.145 - Parental Recognition and Consistency of Noisy Breathing Reports: Treatment and Symptom Associations
D2.148 - Exploring the Role of Bacterial Lysate OM-85 on Immune Mechanisms in Type 2-high Asthma
D3.157 - Clinical characteristics and associated factors of persistent asthma in preschool children with wheezing in a tropical region
D3.165 - Phase 1 study of CDX-622, a bispecific antibody targeting TSLP and mast cells via stem cell factor
D3.155 - Th2–Th17 immune shift following dupilumab therapy
D3.160 - Study of the allergic sensitization profile in asthmatic patients consulting at ignace deen university hospital, conakry
D3.164 - Early and Sustained Effect of Zumilokibart (APG777) in Atopic Dermatitis and Asthma: 16-Week Results from the Phase 2 APEX Study in Moderate-to-Severe AD and a Phase 1b Study in Mild-to-Moderate Asthma
- D3.519 - Post-COVID-19 Reshaping of Molecular IgE Sensitization Profiles to Seasonal and Indoor Allergens
D3.521 - Dermatologic adverse effects of COVID-19 vaccination
- D3.522 - Post-Vaccination SARS-CoV-2 Infections: Evidence, Severity, and Outcomes
D3.523 - Early childhood: a risk predictor for post-COVID-19 pulmonary sequelae in children
- D3.524 - Clinical use of procalcitonin and IL-6 in diagnosis of bacterial superinfection in COVID-19
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download